Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -80.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed -730 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -1979 basis points from the comparable as-filed period.
Net income changed +828.3% from the comparable as-filed period.
Current liabilities changed -35.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed -77.0% from the comparable as-filed period.
Research & development changed -66.1% from the comparable as-filed period.
Debt / assets changed -9362 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed -80.9% from the comparable as-filed period.
Selling, general & administrative changed -70.3% from the comparable as-filed period.
Current assets changed -24.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.